clinical trials observations monoclonal gammopathy undetermined significance mgus consistently precedes multiple myeloma prospective study abstract monoclonal gammopathy undetermined significance mgus premalignant plasma-cell proliferative disorder life-long risk progression multiple myeloma mm mm preceded premalignant asymptomatic mgus stage num num healthy adults enrolled nationwide population-based prospective prostate lung colorectal ovarian plco cancer screening trial identified num subjects developed mm study serially collected num prediagnostic serum samples obtained num num years prior mm diagnosis assays monoclonal proteins electrophoresis/immunofixation kappa-lambda free light chains flcs determined longitudinally prevalence mgus characterized patterns monoclonal immunoglobulin abnormalities prior mm diagnosis mgus present num num num num num num num num num num num num num num num num num num num num num num num num num years prior mm diagnosis approximately half study population m-protein concentration involved flc-ratio levels showed yearly increase prior mm diagnosis present study asymptomatic mgus stage consistently preceded mm molecular markers needed predict progression mm patients mgus 
